Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: Implications for psoriasis pathogenesis

Journal of Investigative Dermatology

Volumn 129, Issue 9, 2009, Pages 2175-2183

  Harper, Erin G ^a   Guo, Changsheng ^b   Rizzo, Heather ^a   Lillis, Joseph V ^a   Kurtz, Stephen E ^b   Skorcheva, Iliyana ^a   Purdy, David ^c   Fitch, Erin ^a   Iordanov, Mihail ^c   Blauvelt, Andrew ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 22; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; EMBRYO; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; TH17 CELL; UPREGULATION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL20; EPIDERMIS; HUMANS; INTERLEUKIN-17; INTERLEUKINS; KERATINOCYTES; MICE; MICE, INBRED BALB C; PSORIASIS; RECEPTORS, CCR6; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349753261     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.65     Document Type: Article

References (39)

1. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007a) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942-949
2. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A et al. (2007b) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8:639-646
3. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B et al. (2007) Phenotypic and functional features of human Th17 cells. J Exp Med 204:1849-1861
4. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG (1999) The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113:752-759
5. Blauvelt A (2007) New concepts in the pathogenesis and treatment of psoriasis: key roles for IL-23, IL-17A and TGF-b1. Expert Rev Dermatol 2:1-10
6. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L et al. (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122:201-206
7. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273-290
8. Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, Abbondanzo S et al. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogen-esis. J Exp Med 203:2577-2587
9. Farley SM, Dotson AD, Purdy DE, Sundholm AJ, Schneider P, Magun BE et al. (2006) Fas ligand elicits a caspase-independent proinflammatory response in human keratinocytes: implications for dermatitis. J Invest Dermatol 126:2438-2451
10. Farley SM, Purdy DE, Ryabinina OP, Schneider P, Magun BE, Iordanov MS (2008) Fas ligand-induced proinflammatory transcriptional responses in reconstructed human epidermis: recruitment of the epidermal growth factor receptor and activation of MAP kinases. J Biol Chem 283:919-928
11. Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9:461-467
12. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204:2803-2812
13. Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E et al. (2000) Up-regulation of macrophage inflammatory protein-3 alpha/ CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164:6621-6632
14. Iordanov MS, Choi RJ, Ryabinina OP, Dinh TH, Bright RK, Magun BE (2002) The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. Mol Cell Biol 22:5380-5394
15. Iordanov MS, Sundholm AJ, Simpson EL, Hanifin JM, Ryabinina OP, Choi RJ et al. (2005) Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitis. J Invest Dermatol 125:134-142
16. Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C et al. (2004) IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173:3482-3491
17. Kao CY, Huang F, Chen Y, Thai P, Wachi S, Kim C et al. (2005) Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway. J Immunol 175:6676-6685
18. Kimball AB, Gordon KB, Langley RG, Menter A, Chartash EK, Valdes JM (2008) Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. Arch Dermatol 144:200-207
19. Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y et al. (2007) A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 356:580-592 (Pubitemid 46220818)
20. Kryczek I, Bruce AT, Gudjonsson JE, Johnston A, Aphale A, Vatan L et al. (2008) Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 181:4733-4741
21. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N et al. (2006) Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ Tcell crosspriming in vivo. Immunity 24:191-201
22. Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F et al. (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199:125-130
23. Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y et al. (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371:1665-1674 (Pubitemid 351671883)
24. Lew W, Bowcock AM, Krueger JG (2004) Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. Trends Immunol 25:295-305
25. Lim HW, Lee J, Hillsamer P, Kim CH (2008) Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol 180:122-129
26. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-1211
27. Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118:597-607
28. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-1160
29. Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N et al. (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371:1675-1684 (Pubitemid 351671884)
30. Paradis TJ, Cole SH, Nelson RT, Gladue RP (2007) Essential role of CCR6 in directing activated T cells to the skin during contact hypersensitivity. J Invest Dermatol 128:628-633
31. Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB (2006) In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol 176:1908-1915
32. Poumay Y, Coquette A (2007) Modelling the human epidermis in vitro: tools for basic and applied research. Arch Dermatol Res 298: 361-369
33. Poumay Y, Dupont F, Marcoux S, Leclercq-Smekens M, Herin M, Coquette A (2004) A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch Dermatol Res 296:203-211
34. Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM (2008) Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 180:214-221
35. Varona R, Cadenas V, Gomez L, Martinez AC, Marquez G (2005) CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses. Blood 106:18-26
36. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957
37. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36:1309-1323
38. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suarez Farinas M, Fuentes-Duculan J et al. (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183-3194
39. Zhou X, Krueger JG, Kao MC, Lee E, Du F, Menter A et al. (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13:69-78